Delivery details +
Order by fax
Genentech, Inc. - Pharmaceuticals & Healthcare
- PDF: Delivered by email usually within 12 to 24 UK business hours.
Genentech, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
- Product Code:GMD12524
- Publication Date:July 2009
- Publisher:Global Markets Direct
- Product Type: Report
- Pages:50
Genentech, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile
Genentech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Genentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacturing, and marketing of biotherapeutics. Genentech is developing the drugs across the unmet medical needs in cancer, asthma and angiogenic disorders. Major focus of Genentech is on three areas namely; oncology, immunology, and tissue growth and repair. The company is headquartered at South San Francisco in California, Unites States. Genentech is acquired by Roche in March 26, 2009. With this acquisition, the company became the wholly owned subsidiary of the Roche Group.
Global Market Direct's Genentech, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table Of Contents
Table Of Contents 2
List of Tables 4
List of Figures 5
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6
Genentech, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 7
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 8
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 9
Genentech, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 10
Genentech, Inc., Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Genentech Acquires Biologics Manufacturing Facility From Biogen Idec 12
Acquisition 13
Roche Acquires Additional 44.2% Stake In Genentech 13
Genentech Acquires Tanox 14
Genentech Completes Public Offering Of 4.40% Senior Notes For $500 Million 15
Genentech Completes Public Offering Of 4.75% Senior Notes For $1,000 Million 16
Genentech Completes Public Offering Of 5.25% Senior Notes For $500 Million 17
Divestiture - Assets 18
Lonza Acquires Manufacturing Facility From Genentech 18
Equity Offering 19
Tercica Completes Private Placement Of $4 Million 19
Partnerships 20
ImmunoGen Extends Its Licensing Agreement With Genentech 20
Thermo Fisher Scientific Enters Into Co-Development Agreement With Genentech 21
Roche Signs An Agreement With Glycart And Genentech 22
Exelixis Enters Into An Co-Development Agreement With Genentech 23
Abbott Laboratories Enters Into An Agreement With Genentech, OSI And Roche 24
Sangamo BioSciences Expands Agreement With Genentech 25
Tercica Enters Into Collaboration Agreement With Genentech 26
Genentech Enters Into Co-Development Agreement With Abbott 27
Sangamo BioSciences Signs An Agreement With Genentech 28
Seattle Genetics Expands Collaboration Agreement With Genentech 29
Genentech Enters Into Licensing Agreement With Seattle Genetics 30
Exelixis Signs Co-Development Agreement With Genentech 31
Genentech Enters Into Licensing Agreement With CGI Pharmaceuticals 32
Genentech Enters Into Co-Development Agreement With Inotek 33
ImmunoGen Signs An Agreement With Genentech 34
Amgen And Genentech Enter Into A Licensing Agreements For Antibody Patents 35
ImmunoGen Extends Its License Agreement With Genentech 36
Lexicon Enters Into A licensing Agreement With Genentech 37
ImmunoGen Extends Its License Agreement With Genentech 38
Genentech Enters Into An Agreement With Protein Design Labs 39
Exelixis Forms Partnership With Genentech 40
ImmunoGen Renews Its Technology Access Agreement With Genentech 41
ImmunoGen Enters Into Licensing Agreement With Genentech 42
Curis Signs Licensing Agreement With Genentech 43
Curis Signs Co-Development Agreement With Genentech 44
Genentech Amends Its Agreement With OSI Pharmaceuticals 45
Genentech Terminates Agreement With Alkermes 46
Venture Financing 47
HistoRx Secures $1.5 Milliion In Series A Financing 47
Key Competitors 48
Key Employees 48
Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Appendix 50
Methodology 50
About Global Markets Direct 50
Contact Us 50
Disclaimer 50
List of Tables
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6
Genentech, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 7
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 8
Genentech, Inc., Deals By Sector, 2004 to YTD 2009 9
Genentech, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 10
Genentech Acquires Biologics Manufacturing Facility From Biogen Idec 12
Roche Acquires Additional 44.2% Stake In Genentech 13
Genentech Acquires Tanox 14
Genentech Completes Public Offering Of 4.40% Senior Notes For $500 Million 15
Genentech Completes Public Offering Of 4.75% Senior Notes For $1,000 Million 16
Genentech Completes Public Offering Of 5.25% Senior Notes For $500 Million 17
Lonza Acquires Manufacturing Facility From Genentech 18
Tercica Completes Private Placement Of $4 Million 19
ImmunoGen Extends Its Licensing Agreement With Genentech 20
Thermo Fisher Scientific Enters Into Co-Development Agreement With Genentech 21
Roche Signs An Agreement With Glycart And Genentech 22
Exelixis Enters Into An Co-Development Agreement With Genentech 23
Abbott Laboratories Enters Into An Agreement With Genentech, OSI And Roche 24
Sangamo BioSciences Expands Agreement With Genentech 25
Tercica Enters Into Collaboration Agreement With Genentech 26
Genentech Enters Into Co-Development Agreement With Abbott 27
Sangamo BioSciences Signs An Agreement With Genentech 28
Seattle Genetics Expands Collaboration Agreement With Genentech 29
Genentech Enters Into Licensing Agreement With Seattle Genetics 30
Exelixis Signs Co-Development Agreement With Genentech 31
Genentech Enters Into Licensing Agreement With CGI Pharmaceuticals 32
Genentech Enters Into Co-Development Agreement With Inotek 33
ImmunoGen Signs An Agreement With Genentech 34
Amgen And Genentech Enter Into A Licensing Agreements For Antibody Patents 35
ImmunoGen Extends Its License Agreement With Genentech 36
Lexicon Enters Into A licensing Agreement With Genentech 37
ImmunoGen Extends Its License Agreement With Genentech 38
Genentech Enters Into An Agreement With Protein Design Labs 39
Exelixis Forms Partnership With Genentech 40
ImmunoGen Renews Its Technology Access Agreement With Genentech 41
ImmunoGen Enters Into Licensing Agreement With Genentech 42
Curis Signs Licensing Agreement With Genentech 43
Curis Signs Co-Development Agreement With Genentech 44
Genentech Amends Its Agreement With OSI Pharmaceuticals 45
Genentech Terminates Agreement With Alkermes 46
HistoRx Secures $1.5 Milliion In Series A Financing 47
Genentech, Inc., Key Employees 48
Genentech, Inc., Other Locations 49
List of Figures
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 6
Genentech, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 7
Genentech, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 8
Genentech, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 9
